(HealthDay)—In critically ill patients, proton pump inhibitor (PPI) use is not associated with cardiac arrhythmia, according to a study published online Feb. 6 in the Journal of Clinical Pharmacology.
Feb 24, 2015
0
3
(HealthDay)—For medical students, self-reported confidence in prescribing only weakly correlates with actual competence, according to a study published online Feb. 4 in The Journal of Clinical Pharmacology.
Feb 10, 2015
0
6
Recent research has revealed that many children and adults with autism experience gastrointestinal symptoms and that such symptoms can impact the absorption and availability of medications.
Sep 2, 2014
0
0
Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results ...
Sep 24, 2013
0
0
A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.
Mar 22, 2013
0
0
(Medical Xpress)—A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found ...
Mar 21, 2013
0
0
The bacteria that cause acne live on everyone's skin, yet one in five people is lucky enough to develop only an occasional pimple over a lifetime. What's their secret?
Feb 28, 2013
0
0
Drugs that bind to specific serotonin receptors in the brain can both improve and impair female sexual function in non-human primates. These are the findings of a study conducted by Leiden PhD candidate Yves Aubert and colleagues ...
Dec 12, 2012
0
0
Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography ...
Dec 10, 2012
0
0
(HealthDay)—Although use of recombinant human erythropoietin (rHuEPO) is prohibited among athletes because it reportedly enhances performance, there is no scientific evidence that it does so, according to a study published ...
Dec 10, 2012
0
0
